Remove tag tracking
article thumbnail

Genprex’s Reqorsa gene therapy picks up orphan drug designation from FDA for SCLC

Pharmaceutical Technology

The latest tag adds to three fast track designations for Reqorsa, with the company initiating a Phase I/II trial in Q4 2023.

96
article thumbnail

Pfizer and Arvinas win UK’s fast track tag for breast cancer drug

Pharmaceutical Technology

Vepdegestrant was awarded the Innovation Passport designation for treating advanced or metastatic breast cancer.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PharmaShots Weekly Snapshots (April 10 - 14, 2023)

PharmaShots

Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)

article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

Smart packaging has potential for the integration of electronic functionality, enabling compliance, material identification, condition monitoring and asset tracking of pharmaceutical products. Yet apart from radio-frequency identification (RFID) tags and QR codes, adoption at scale has proved challenging overall, the report stated.

article thumbnail

Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA

pharmaphorum

Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer’s programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up to recently approved Aduhelm. The post Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA appeared first on.

111
111
article thumbnail

Generative AI with Google Lens to detect counterfeits in pharma

Express Pharma

Generative AI will be used to create unique invisible image tags for each product (like UID). This can be done by training the AI on a dataset of existing batch numbers, allowing it to generate new, unique invisible image tags on brand logo / brand name that cannot be replicated by counterfeiters 2. Key features and benefits a.

article thumbnail

bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies

Pharmaceutical Technology

Spark Therapeutics’ Luxturna, indicated for inherited retinal disease (IRD), was the first gene therapy to be approved, in 2017, with a price tag of $850,000 for each eye. Prior to bluebird's approvals, there were only two FDA-approved gene therapies for inherited conditions on the market.

115
115